PubRank

D W Cockcroft

Author PubWeight™ 211.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prediction of creatinine clearance from serum creatinine. Nephron 1976 64.02
2 Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977 14.37
3 Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000 9.44
4 Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978 4.77
5 Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977 4.42
6 Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 3.82
7 Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995 2.47
8 Protective effect of drugs on histamine-induced asthma. Thorax 1977 2.02
9 Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987 1.78
10 Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997 1.71
11 Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol 1981 1.66
12 Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996 1.65
13 Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol 1979 1.60
14 Mechanism of perennial allergic asthma. Lancet 1983 1.58
15 Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol 1998 1.58
16 Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980 1.57
17 Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis 1979 1.57
18 OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy 2014 1.54
19 Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis 1977 1.53
20 Methacholine PC20 extrapolation. Chest 1998 1.50
21 Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009 1.45
22 Right-sided aortic arch presenting as refractory intraoperative and postoperative wheezing. Chest 1991 1.45
23 Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest 1983 1.44
24 Indirect airway challenges. Eur Respir J 2003 1.42
25 Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995 1.25
26 Calcitonin from ultimobranchial glands of dogfish and chickens. Science 1967 1.20
27 Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987 1.16
28 Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax 1983 1.13
29 Ultimobranchial origin of calcitonin. Hypocalcemic effect of extracts from chicken glands. Can J Physiol Pharmacol 1967 1.12
30 Factors in allergen-induced asthma: relevance of the intensity of the airways allergic reaction and non-specific bronchial reactivity. Clin Allergy 1976 1.11
31 Increased bronchial reactivity to inhaled histamine in nonsmoking grain workers with normal lung function. Chest 1980 1.08
32 Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis 1984 1.08
33 Asthma caused by occupational exposure to a furan-based binder system. J Allergy Clin Immunol 1980 1.08
34 Nonspecific bronchial hyperreactivity after exposure to Western Red Cedar. Am Rev Respir Dis 1979 1.08
35 Miliary tuberculosis presenting with hyponatremia and thrombocytopenia. Can Med Assoc J 1976 1.07
36 Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993 1.06
37 Determination of histamine PC20. Comparison of linear and logarithmic interpolation. Chest 1983 1.05
38 Assessment of endotoxin levels in the home and current asthma and wheeze in school-age children. Indoor Air 2008 1.05
39 Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol 2004 1.05
40 Bronchial response to inhaled histamine in asymptomatic young smokers. Eur J Respir Dis 1983 1.02
41 Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered 1990 1.01
42 The beta-agonist controversy. Med Clin North Am 1996 1.00
43 The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 2007 0.98
44 Cigarette smoking, airway hyperresponsiveness, and asthma. Chest 1988 0.97
45 Out-patient management of bronchial asthma. Can Fam Physician 1989 0.96
46 Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine. Thorax 1983 0.96
47 Asthma management in the emergency department. Can Respir J 2000 0.96
48 Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000 0.96
49 Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax 1987 0.94
50 Volume adjustment of maximal midexpiratory flow. Importance of changes in total lung capacity. Chest 1980 0.94
51 Decrease in non-specific bronchial reactivity in an asthmatic following treatment of hyperthyroidism. Ann Allergy 1978 0.93
52 Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1999 0.92
53 Characteristics of airway tone during exercise in patients with asthma. J Appl Physiol Respir Environ Exerc Physiol 1983 0.92
54 Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J 1976 0.91
55 Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model. J Allergy Clin Immunol 1997 0.91
56 Standardization of inhalation provocation tests. Dose vs concentration of histamine. Chest 1982 0.91
57 Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977 0.90
58 Occupational asthma caused by cedar urea formaldehyde particle board. Chest 1982 0.90
59 Self-injection with olive oil. A cause of lipoid pneumonia. Chest 1995 0.90
60 Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J 1979 0.89
61 Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection. Chest 2001 0.89
62 Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol 1996 0.89
63 Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J 1981 0.89
64 Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society. Eur Respir J 1998 0.89
65 Effect of Sch1000 in allergen-induced asthma. Clin Allergy 1978 0.88
66 How best to measure airway responsiveness. Am J Respir Crit Care Med 2001 0.87
67 Pulmonary function in Pi M and MZ grainworkers. Chest 1986 0.87
68 Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ 1995 0.87
69 Correlation of bronchial responsiveness to diluent and to histamine. Ann Allergy 1982 0.87
70 Respiratory health risks in farmers. Ann Intern Med 1981 0.86
71 Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med 1991 0.85
72 Constrictive bronchiolitis and ulcerative colitis. Can Respir J 1999 0.85
73 Bronchial inhalation tests. I. Measurement of nonallergic bronchial responsiveness. Ann Allergy 1985 0.85
74 Increased airways responsiveness in swine farmers. Chest 1991 0.85
75 Acquired persistent increase in nonspecific bronchial, reactivity associated with isocyanate exposure. Ann Allergy 1982 0.85
76 The effect of helium on nasal resistance and nasal flows. Am Rev Respir Dis 1979 0.84
77 Effect of pH on bronchial response to inhaled histamine. Thorax 1982 0.84
78 Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J 2003 0.84
79 The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J 1991 0.84
80 Nasal airway inspiratory resistance. Am Rev Respir Dis 1979 0.83
81 Letter: Creatinine clearance and age. Lancet 1975 0.83
82 Measurement of responsiveness to inhaled histamine: comparison of FEV1 and SGaw. Ann Allergy 1983 0.83
83 Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy 1979 0.83
84 Airway responsiveness to inhaled histamine in chronic obstructive airways disease. Chronic bronchitis vs emphysema. Chest 1988 0.83
85 [Airway response. Standardized provocation tests in adults: pharmacological, physical and sensitizing stimuli. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]. Rev Mal Respir 1994 0.82
86 Occupational obstructive disorders: nonspecific airways obstruction and occupational asthma. Med Clin North Am 1990 0.82
87 Ethnicity as a possible factor contributing to the development of chronic airflow limitation and asthma. Clin Invest Med 1990 0.82
88 Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol (1985) 1989 0.82
89 Sporobolomyces: a possible cause of extrinsic allergic alveolitis. J Allergy Clin Immunol 1983 0.82
90 Lobar pneumonia caused by Mycoplasma pneumoniae. Can Med Assoc J 1981 0.81
91 Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol 1998 0.81
92 Eosinophilic bronchitis as a cause of cough. Chest 2000 0.81
93 Localization of emphysema within the lung. An hypothesis based upon ventilation/perfusion relationships. Chest 1982 0.80
94 Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. Respir Med 1990 0.79
95 Risk factors for reduced pulmonary function in women. A possible relationship between Pi phenotype, number of children, and pulmonary function. Chest 1992 0.79
96 The effect of atropine on allergen-induced increases in bronchial responsiveness to histamine. Am Rev Respir Dis 1984 0.79
97 Subsittution of inhaled beclomethasone dipropionate for ingested prednisone in steroid-dependent asthmatics. Can Med Assoc J 1977 0.79
98 A comparison of the protective effect of fenoterol and Sch 1000 on allergen-induced asthma. J Allergy Clin Immunol 1978 0.79
99 Ethnic differences in the prevalence of pulmonary airflow obstruction among grain workers. Chest 1989 0.79
100 Severe acute "occupational asthma" caused by accidental allergen exposure in an allergen challenge laboratory. Ann Allergy 1985 0.79
101 Lower prevalence of positive atopic skin tests in lung cancer patients. Chest 1988 0.79
102 Occupational asthma caused by exposure to cooking lobster in the work environment: a case report. Ann Allergy 1992 0.78
103 Practical issues in asthma management: correct use of inhalation devices. Ann Allergy 1993 0.78
104 Inhalant atopic sensitivity to grasshoppers in research laboratories. J Allergy Clin Immunol 1993 0.78
105 Prediction of nonresponse to corticosteroids in stable chronic airflow limitation. Clin Invest Med 1991 0.78
106 Lymphocytic interstitial pneumonia and abdominal lymphoma complicating celiac sprue. J Clin Gastroenterol 1986 0.77
107 The bronchial late response in the pathogenesis of asthma and its modulation by therapy. Ann Allergy 1985 0.77
108 Allergen injection therapy with glutaraldehyde-modified--ragweed pollen-tyrosine adsorbate. A double-blind trial. J Allergy Clin Immunol 1977 0.77
109 Farming and exposure to chemicals in male lung cancer patients and their siblings. J Occup Med 1988 0.77
110 Pi type MZ and an increased risk of pneumonia. Clin Invest Med 1984 0.76
111 Inhaled beta 2-agonists and allergen-induced airway responses. J Allergy Clin Immunol 1995 0.76
112 Calculation of provocative concentration causing a 20% fall in FEV(1): comparison of lowest vs highest post-challenge FEV(1). Chest 2000 0.76
113 Beta-agonists and bronchial asthma. Chest 1994 0.75
114 Output of the Wright jet nebulizer. Eur Respir J 1990 0.75
115 Regularly scheduled inhaled bronchodilators and maintenance asthma therapy. Chest 2001 0.75
116 Endobronchial lipoma: two cases and review of the literature. Can Med Assoc J 1976 0.75
117 Intracerebral abscess: a complication of severe cystic fibrosis lung disease. Can Respir J 2008 0.75
118 Salmeterol, inhaled corticosteroids, and tolerance to allergen bronchoprotection. Chest 1999 0.75
119 Clinical trials needed for alpha 1-antitrypsin replacement therapy. Chest 1995 0.75
120 Treatment of asthma during pregnancy. Ann Allergy Asthma Immunol 2005 0.75
121 Beta-agonists, airway hyperresponsiveness, and asthma. J Allergy Clin Immunol 1992 0.75
122 The evaluable subject. Ann Allergy Asthma Immunol 1998 0.75
123 Dose versus concentration of methacholine. Ann Allergy Asthma Immunol 1999 0.75
124 Determination of post-salbutamol methacholine dose shift. Chest 1996 0.75
125 Endobronchial hamartoma. A case report. S Afr Med J 1992 0.75
126 Bronchial inhalation tests. II. Measurement of allergic (and occupational) bronchial responsiveness. Ann Allergy 1987 0.75
127 Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol. Curr Ther Res Clin Exp 1976 0.75
128 Lung disease due to abuse of hairspray. Arch Pathol Lab Med 1981 0.75
129 Occupational asthma caused by pea flour. Chest 1995 0.75
130 Cytokine expression on cross-linking of human tissue Fc epsilon RI. Int Arch Allergy Immunol 1997 0.75
131 Protease inhibitor phenotype BsaskatoonM is not associated with emphysema - a 20-year follow-up study. Can Respir J 1999 0.75
132 Lack of Hardy-Weinberg equilibrium among PiM phenotypes suggests difficulty distinguishing between some M subtypes. Chest 1983 0.75
133 A new anodal alpha 1-antitrypsin variant associated with emphysema: Pi Bsaskatoon. Am Rev Respir Dis 1982 0.75
134 Failure to produce late asthmatic responses after ingestion of allergen. J Allergy Clin Immunol 1988 0.75
135 Recurrent nocturnal asthma after bronchoprovocation with Western Red Cedar sawdust: association with acute increase in non-allergic bronchial responsiveness. Clin Allergy 1984 0.75
136 Airflow obstruction and roadside breath alcohol testing. Chest 1991 0.75
137 [Bronchial hyperreactivity other than that seen in asthma]. Rev Mal Respir 1994 0.75
138 Effect of cold air on the bronchial response to inhaled histamine in patients with asthma. Am Rev Respir Dis 1991 0.75
139 Airways obstruction in occupational pulmonary disease. Med Clin North Am 1981 0.75
140 Relationship between bronchial response to respiratory heat exchange and nonspecific airways reactivity in asthmatic patients. Chest 1984 0.75
141 The effect of repirinast on airway responsiveness to methacholine and allergen. J Allergy Clin Immunol 1992 0.75
142 Pi MZ phenotype and an increased prevalence of reported psoriasis in a community survey. Hum Hered 1986 0.75